Irene S.
- Country
- Austria
- Department
- I. Internal department Hematology and Oncology
Research Overview
- A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing Mezigdomide (CC-92480/BMS-986348), Carfilzomib, and Dexamethasone (MeziKd) Versus Carfilzomib and Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM): SUCCESSOR-2
- Evaluation of Minimal Residual Disease Techniques in Untreated Multiple Myeloma with Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone Therapy
- Phase 3 Evaluation of Teclistamab with Lenalidomide versus Lenalidomide Monotherapy in Maintenance Therapy for Newly Diagnosed Multiple Myeloma Post-ASCT
Data & Insights
Has run more than one trial at 240 of 394 partner sites.
Specializations
Multiple Myeloma Treatment Approaches
This investigator specializes in evaluating novel therapeutic strategies for multiple myeloma, with particular focus on both newly diagnosed cases and relapsed/refractory disease states.
- Combination Therapy Development
- CAR T-Cell Therapy Assessment
- Immunotherapy Integration
Their research encompasses innovative treatment combinations incorporating monoclonal antibodies and novel therapeutic agents.
Therapeutic Innovation
The investigator studies cutting-edge treatments including cell-based therapies and targeted approaches for multiple myeloma management.
- Novel Drug Evaluation
- Maintenance Therapy Optimization
- Treatment Sequencing Strategies
Their work involves assessment of various administration routes and therapeutic combinations to enhance treatment outcomes.
Clinical Outcomes Research
The investigator focuses on evaluating treatment efficacy through minimal residual disease assessment and progression-free survival metrics.
- Response Assessment Methods
- Disease Monitoring Techniques
- Treatment Response Evaluation
Their research includes comparative analyses of different therapeutic approaches in various multiple myeloma settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.